These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11333292)

  • 1. p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.
    Done SJ; Eskandarian S; Bull S; Redston M; Andrulis IL
    J Natl Cancer Inst; 2001 May; 93(9):700-4. PubMed ID: 11333292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In microdissected ductal carcinoma in situ, HER-2/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histology.
    Ho GH; Calvano JE; Bisogna M; Borgen PI; Rosen PP; Tan LK; Van Zee KJ
    Cancer; 2000 Dec; 89(11):2153-60. PubMed ID: 11147584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
    Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
    Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
    Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
    Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast.
    Iwase H; Ando Y; Ichihara S; Toyoshima S; Nakamura T; Karamatsu S; Ito Y; Yamashita H; Toyama T; Omoto Y; Fujii Y; Mitsuyama S; Kobayashi S
    Breast Cancer; 2001; 8(2):98-104. PubMed ID: 11342981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
    Chitemerere M; Andersen TI; Holm R; Karlsen F; Børresen AL; Nesland JM
    Breast Cancer Res Treat; 1996; 41(2):103-9. PubMed ID: 8944328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.
    Lisboa BW; Vogtländer S; Gilster T; Riethdorf L; Milde-Langosch K; Löning T
    Virchows Arch; 1997 Dec; 431(6):375-81. PubMed ID: 9428925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. No correlation.
    Douglas-Jones AG; Navabi H; Morgan JM; Jasani B
    Virchows Arch; 1997 May; 430(5):373-9. PubMed ID: 9174627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein expression in ductal carcinoma in situ (DCIS) of the breast.
    Rajan PB; Scott DJ; Perry RH; Griffith CD
    Breast Cancer Res Treat; 1997 Feb; 42(3):283-90. PubMed ID: 9065612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-2 expression in the spectrum of preinvasive breast lesions.
    Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
    Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
    Munn KE; Walker RA; Menasce L; Varley JM
    Br J Cancer; 1996 Nov; 74(10):1578-85. PubMed ID: 8932338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive apoptosis in ductal carcinoma in situ of the breast.
    Bodis S; Siziopikou KP; Schnitt SJ; Harris JR; Fisher DE
    Cancer; 1996 May; 77(9):1831-5. PubMed ID: 8646681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.
    Allred DC; Wu Y; Mao S; Nagtegaal ID; Lee S; Perou CM; Mohsin SK; O'Connell P; Tsimelzon A; Medina D
    Clin Cancer Res; 2008 Jan; 14(2):370-8. PubMed ID: 18223211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene amplifications detected by fluorescence in situ hybridization in pure intraductal breast carcinomas: relation to morphology, cell proliferation and expression of breast cancer-related genes.
    Fiche M; Avet-Loiseau H; Maugard CM; Sagan C; Heymann MF; Leblanc M; Classe JM; Fumoleau P; Dravet F; Mahé M; Dutrillaux B
    Int J Cancer; 2000 Sep; 89(5):403-10. PubMed ID: 11008201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
    Maxhimer JB; Pesce CE; Stewart RA; Gattuso P; Prinz RA; Xu X
    J Am Coll Surg; 2005 Mar; 200(3):328-35. PubMed ID: 15737842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
    Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P
    J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.
    Done SJ; Arneson CR; Ozçelik H; Redston M; Andrulis IL
    Breast Cancer Res Treat; 2001 Jan; 65(2):111-8. PubMed ID: 11261826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.